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Abstract. We compared blood loss and hemostasis in pigs 
which had undergone either orthotopic liver transplanta- 
tion (OLT) (group A, n = 12) or auxiliary heterotopic par- 
tial liver transplantation (APLT) (group B, n = 11). Blood 
samples were taken at regular intervals during and after 
the operations. In both groups, nine animals survived 
longer than 24 h and data from these animals were used 
for analysis. Median (range) intraoperative blood loss was 
825 ml (250-1500 ml) in OLT and 425 ml (300-750) in 
APLT ( P  c 0.01). Routine clotting times, as the activated 
partial thromboplastin time, prothrombin time and 
thrombin time, showed no major intraoperative changes 
in either group. Fibrinogen levels decreased in both 
groups, but no significant difference was found between 
the two groups. The only significant difference between 
group A and B was a more sustained increase in fibrino- 
lytic activity after graft recirculation in group A. Post- 
operatively, restoration of fibrinogen, antithrombin-111 
and cr,-antiplasmin levels was slightly faster in group B, 
resulting in significantly higher levels during the first day. 
We conclude that, in this animal model, APLT is associ- 
ated with significantly lower blood loss and less severe fi- 
brinolytic activity, than OLT. This difference might result 
from the lack of an anhepatic period and the reduced sur- 
gical trauma in auxiliary heterotopic liver transplantation. 
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Although orthotopic liver transplantation (OLT) has 
become an accepted method to treat patients with end- 
stage chronic liver disease, it is still associated with massive 
intraoperative blood loss and the use of large amounts of 
blood products [9,17]. Excessive blood loss is associated 
with an increased perioperative mortality and morbidity 
[32]. Massive transfusion ofblood productsalsocontributes 
significantly to the totalcost of liver transplantation [32]. 
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Bleeding of surgical origin may be seriously compli- 
cated by specific hemostatic deteriorations, which occur 
especially during the anhepatic and post-anhepatic periods 
[9,24]. Disseminated intravascular coagulation (DIC), pri- 
mary increased fibrinolysis, or a combination of both pro- 
cesses, have been suggested as a major cause of bleeding in 
orthotopic liver transplantation [12,13,21,24].Lackof he- 
patic clearance of activated coagulation factors or activa- 
torsof the fibrinolyticsystemmay lead to severe disturban- 
ces of the hemostasissystemin the anhepatic phase of OLT 
[lo, 181. 
Auxiliary heterotopic liver transplantation has been 
proposed as an alternative to hepatic replacement. The 
main theoretical advantage of auxiliary liver transplanta- 
tion is avoidance of the technical hazards of recipient he- 
patectomy and the lack of an anhepatic period [7,29]. A 
second advantage may be that the recipient is not, at the 
outset, totally dependent on the function of the homo- 
graft. These differences might contribute to less severe he- 
mostatic disorders and the usage of smaller amounts of 
blood products. However, information on this technique 
and its effect on hemostasis is limited. 
Auxiliary heterotopic liver transplantation, though at- 
tractive, cannot be regarded as an alternative at present, 
and is probabIy limited to specific indications. Only a 
small number of auxiliary liver transplantations have been 
performed in humans [7,30]. The initial discouraging re- 
sults have held up further application of this technique. 
Recently, many of the technical problems seem to have 
been resolved by improving the procedure and by using a 
partial graft [26,27]. The first clinical applications suggest 
that this improved technique of auxiliary partial liver 
transplantation (APLT) can be performed successfully 
without serious changes in blood coagulation and fibrino- 
lysis, even in patients with poor preoperative hemostatic 
function [15, 23,311. However, objective information on 
the advantages and disadvantages of both techniques of 
liver transplantation can only be obtained from studies in 
which both techniques are evaluated under identical con- 
ditions. In addition, comparison of the two techniques can 
provide interesting information regarding the role of the 
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portal and femoral vein to the jugular vein, using a heparin-coated 
extracorporeal circuit [S]. No systemic heparin was given. 
Tablc 1. Body weight. intraoperative blood loss and infusion fluids 
in pigs that underwent orthotopic (OLT) and auxiliary partial 
(APLT) liver transplantation. Values are median (range). NS, Not 
significant 
Group A (OLT) Group B (APLT) Signifi- 
(n =9) (n =9) cance 
Body weight (kg) 26.4 (18.5-28.0) 22.5 (20.0-30.0) NS 
Blood loss (mi) 825 (250-1500) 425 (300-750) P c 0.01 
Ringers solution (ml) 7250 (1500-33OO) 1500 (1500-3500) NS 
Haemaccel (ml) 2250 ( 1 5 0 0 - 4 ~ )  1750(1500-2500) NS 
anhepatic phase and graft reperfusion in the origin of he- 
mostatic disorders during OLT. 
Therefore, we undertook a comparative study of OLT 
and APLT in healthy pigs. The effect of pre-existing dif- 
ferences in coagulation defects, as may be found inliverpa- 
tients, was thusavoided, whichmade it possible tostudy the 
changes in hemostasis during specific stages of the surgical 
procedures.This study formed part of a larger comparative 
study on surgical and anesthetic management in OLT and 
APLT, part of which has been described elsewhere [3]. 
Materials and methods 
Twenty-three female Yorkshire pigs were used in the experiments. 
The study was approved by the Committee for Laboratory Animal 
Research of the Erasmus University, Rotterdam. The animals were 
randomly allocated to two groups: animals in group A (n = 12) 
underwent OLT and those in group B (n = 11) underwent APLT. 
The donor and recipient were matched according to a negative reac- 
tion in the mixed lymphocyte culture test (MLC) [ 191. 
All operations were carried out under general anesthesia and the 
animals were ventilated using a Siemens 900B Servo ventilator. Dur- 
ing the operations. Ringers solution and Haemaccel were given for 
hemodynamic support as needed. Depending on the amount of 
blood loss, 1-2 IU whole blood (400 ml each) was given in the period 
after graft recirculation. 
Donor hepatectomy was performed using a conventional tech- 
nique. After harvesting, the donor liver was perfused ex vivo by 
portal vein cannulation with 1 1 Euro-Collins (CC) and grafted with- 
in 4 h. Details of the surgical technique used are given below. 
Orlhotopic liver transplantation 
In group A, OLT was performed by a standard procedure [ZS]. Dur- 
ing the anhepatic period, blood flow from the operative area and the 
inferior part of the body was shunted away by a bypass from the 
Table 2. Survival and causes of death after or- 
thotopic (OLT) and auxiliary partial (APLT) 
liver transdantation 
- 
Pig 
no. 
1 
2 
3 
4 
5 
6 
7 
8 
9 - 
Heterotopic, auxiliary liver transplantation 
In group B, APLT was performed by using a partial liver graft. Dur- 
ing bench surgery the left medial and lateral lobes of the liver were 
resected as described previously [26]. The partial graft, consisting of 
about 65% of the donor liver, was placed in the right subhepatic 
space, anastomosing the suprahepatic vena cava of the graft end-to- 
side to the infrahepatic vena cava of the recipient. The donor portal 
vein was anastomosed end-to-side to the recipient portal vein and 
an end-to-side anastomosis was made between the graft hepatic ar- 
tery to the recipient's infrarenal aorta. Bile flow was reconstituted 
by a choledochoduodenostomy. In this type of liver transplantation 
no shunt is necessary for the decompression of the splanchnic circu- 
lation during portal clamping. None of the animals received sys- 
temic heparin. No immunosuppressive drugs were given in either 
group. 
Blood loss and blood sampling 
Blood loss was quantified by measuring the amount of blood sucked 
away from the surgical field, and collected in Buleaux bottles during 
the operation. 
Intraoperative blood samples (20 ml) were taken from an arte- 
rial line, while in the postoperative period blood was collected from 
a central venous line or by puncturing the jugular vein. A part of the 
blood sample (18 ml) was divided into two polystyrene test tubes, 
containing 1 ml ice-cold trisodium citrate 0.11 mol/l (9 vol + 1 vol) 
and immediately placed on melting ice. Plasma was collected after 
centrifugation (2800 g, 4'C. 30 min), snap-frozen and stored in small 
aliquots at - 70'C until used. A smaller part of the blood sample 
(2 ml) wascollected into0.045 ml15% solution of6.75 mg EDTA. 
In both groups preoperative blood samples were taken immedi- 
ately after induction of ancsthesia. The other blood samples were 
taken 5 min after anastomosis of the portal vein (recirculation of the 
graft), 5 min after anastomosis of the hepatic artcry, 2 h and 3 h after 
transplantation and on postoperative days 1,2, 7, 10, 14 and 21. In 
group A(OLT),one extra bloodsample was taken 10 min before the 
end of the anhepatic phase. 
Hemostasis stiidies 
Cuagduriun. The activated partial thromboplastin time (APTT), 
prothrombin time (PT) and thrombin time (ThT) were measured as 
described previously [22]. Thrombelastography (TEG) was per- 
formed in citrated plasma [20]. The r-value was defined as the time 
interval between the start of the registration and the first deflection 
on the TEG recording. The k -value was defined as the time interval 
after the first deflection until an amplitude of 10 mm was reached. 
Group A (OLT) 
Survival Cause of death Survival Cause of death 
Group B (APLT) 
(days) (days) 
7 Rejection 35 Sacrificed in good health 
17 Cholangitis 8 Volvulus of jejunum 
2 Not clear 1.5 Volvulus of jejunum 
94 Sacrificed in good health 50 Sacrificed in good health 
72 Sacrificed, leg abscess 86 Sacrificed in good health 
33 Not clear 91 Strangulated hernia 
25 Cholangitis 159 Sacrificed in good health 
5 Volvulus of jejunum 93 Sacrificed in good health 
38 Bile leakage 23 Purulent pneumonia 
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The maximum amplitude (MA) represented the maximum deflec- 
tion on the TEG recording. Fibrinogen was measured according to 
the method of Clauss [4] and antithrombin411 (AT-111) activity was 
assayed as described by Abildgaard et al. 111. The vitamin K depen- 
dent factors 11, VII and IX were determined by Normotest, accord- 
ing to  the manufacturer's instructions (Nyegaard Diagnostica, Oslo, 
Norway). The hematocrit of each blood sample was measured to de- 
tect possible dilution effects. 
Fibrinolysis. To determine the euglobulin clot lysis time (ECLT), 
standard euglobulin fractions of plasma were prepared at pH 5.9 
with a plasma dilution of 1:lO [14]. Precipitates were redissolved in 
Trisnween buffer (0.1 M TRIS/HCI, containing 0.1% v/v 
Tween 80, pH 7.5). and to 0.2 ml aliquots of the dissolved euglo- 
bulin fractions 0.1 ml portions of calcium thrombin solution (CaCI2 
25 mmoVl and thrombin 10 NIH IU/l) were added t o  induce clot 
formation. The lysis time of the clot was recorded. The disappear- 
ance of air bubbles was regarded as the endpoint of lysis. a2-Anti- 
plasmin (a2-AP) activity was measured according to the method of 
Friberger et al. [S]. Plasminogen was assayed in acidified plasma 
using urokinase (Choay, Paris, France) for activation of plasmi- 
nogen and 5-2251 (Kabi Vitrum Haematology, Amsterdam, The 
Netherlands) as substrate [19]. 
Statistical analysis 
Statistical analysis was performed using the Wilcoxon signed rank 
test for paired data and the two-sample test for unpaired data. 
Values at P c 0.05 were considered to be significant. 
Results 
In both groups nine animals survived longer than 24 h 
after transplantation and the data of these animals were 
used for analysis. The excluded animals died of second- 
Fig.l. A APTT, P?; r-value, k-value and 
maximum amplitude (MA) of 
thrombelastogram in animals that 
underwent liver transplantation. 0 OLT - 
(group A); 0 APLT (group B) (median 
values). B Fibrinogen, AT-III, platelet 
count and hematocrit (Hr). 0 OLT 
(group A); 0 APLT (group B) (median 
values). P c 0.05, comparison between 
group A and B. 0 Preoperative; I end 
anhepatic phase in OLT2 5 min after 
recirculation; 3 5 min after hepatic artery 
anastomosis; 4 2 h postoperative; 5 3 h 
postoperative. Median (range) time 
interval between 0 and 2 for OLT, 194 
(144-250) min; for APLT, 120 
(9CL180) min; between 2 and 3 for OLT, 
43 (30-70) min; for APLT 40 (25-105) min 
ary complications which needed extensive therapeutic in- 
terventions, such as cardiac resuscitation, and which in- 
terfered with the standard surgical and anesthetic proce- 
dures essential for this study. In Table 1 body weight, 
blood loss and the amount of infusion fluids in group A 
(OLT) and groupB (APLT) are compared. Median in- 
traoperative blood loss in groupA (OLT) was about 
twice as much as in group B (APLT) ( P  c0.01) Survival 
and causes of death in both groups are shown in Table 2. 
None of the animals died of postoperative hemorrhage. 
The main causes of early mortality were secondary to 
surgery and included intestinal strangulations. Autopsy 
demonstrated vital donor livers, with patency of all vas- 
cular anastomoses in all but one case in group A (no. 1). 
The graft of this animal was firm and signs of intrahepatic 
cholestasis were present. In group B (APLT), vital grafts 
with patent vascular anastomoses were found in 5 of 7 
animals for which autopsy data were available. In two 
animals (nos. 6 and 7) a pale, firm and atrophic auxiliary 
graft was found. 
Coagulation 
Intraoperatively, none of the investigated coagulation 
parameters was different between the two groups. A 
rather stable course of APTT and PT was found in both 
groups (Fig. 1 A), as also was found for ThT and NT. In 
fact, the only coagulation parameter that showed impor- 
tant changes during the operations was fibrinogen, for 
which a more than 40% decrease of the median levels was 
found during the operations in both groups (Fig. 1 B). This 
was also reflected by a prolongation of the k -value and a 
decrease of the MA on the TEG recordings (Fig. 1 A). 
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and a2-AP levels on the first day after surgery were higher 
in group B (APLT) ( P  c 0.01) (Fig. 3). Fibrinogen levels 
showed a peak on day 2 in group A (OLT) and on days 1 
and 2 in group B (APLT) (Fig.3). Platelet count reduced 
further during the first postoperative days, reaching a 
minimum on the second day in both groups. Thereafter a 
rapid recovery of platelet count was observed, rcsulting in 
a thrombocytosis (median values higher than 500 x 109/1) 
at the end of the first week (Fig. 3). 
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Fig.2. ECLZ plasminogen and az-antiplasmin (a,-AP) in animals 
that underwent liver transplantation. 0 OLT (group A); 0 APLT 
(group B) (median values). P c 0.05, comparison between 
group A and B. X-axis notation as in Fig. 1 
These changes could not be explained by hemodilution 
since no important changes in hematocrit were found 
(Fig. 1 B). A slowly decreasing pattern was also seen for 
AT-111 and platelet count (Fig. 1 B). 
Fibrinolysis 
Important intraoperative changes were found in the in- 
vestigated fibrinolytic parameters in both groups. Hyper- 
fibrinolysis, as characterized by shortened ECLTs and re- 
duction of a2-AP and plasminogen concentrations, was 
found 5 min after graft reperfusion in both OLT and 
APLT (Fig. 2). During OLT an increased fibrinolytic ac- 
tivity, as measured by ECLT, was already present during 
the anhepatic period. In group A (OLT) a further increase 
of fibrinolytic activity was seen during the postreperfu- 
sion period, resulting in significantly shorter ECLTs at the 
time of completion of the arterial anastomosis, compared 
with group B (APLT) (P ~0.05). In both groups, ECLT 
became normal ( > 180 s) 3 h after the operation. At this 
time plasma levels of plasminogen and a2-AP were still re- 
duced. Restoration of a2-AP levels was apparently faster 
in group B (APLT), but the difference was not statistically 
significant. 
Long-term postoperative changes 
In both groups, a recovery of hemostatic parameters was 
observed during the first postoperative week. There were 
no differences in APTT, PT and NT. Fibrinogen, AT-I11 
- 
Discussion 
The anhepatic phase in OLT is associated with serious 
changes in hemostasis, which may further complicate sur- 
gical bleeding and contribute to the need for massive 
blood transfusions [12,24]. Auxiliary liver transplanta- 
tion potentially has benefits over OLT, as the technical 
hazards of the recipient hepatectomy and the subsequent 
anhepatic period are avoided. Therefore, auxiliary liver 
transplantation may, theoretically, be associated with less 
severe hemostatic deterioration, and it may be an attrac- 
tive alternative to OLT. However, objective evidence on 
the potential advantages of auxiliary liver transplantation, 
with regard to blood loss and disturbances of hemostasis, 
are lacking. Although a comparison of OLT and auxiliary 
liver transplantation has been made in a previous study, 
this was primarily designed to study the effect of graft 
preservation damage on hemostasis, and insight into the 
specific changes due to the auxiliary transplantation pro- 
cedure cannot be obtained from this study [ll]. 
In the present study we investigated hemostasis after 
OLT and APLT using techniques which are currently used 
in humans. Both types of liver transplantation were per- 
formed in a controlled study in healthy pigs. The effects of 
pre-existing differences on coagulation defects, as may 
occur in liver patients, were thus avoided. This made it 
possible to study the specific changes in hemostasis due to 
the surgical procedures only. It should be noted that the 
results obtained in healthy pigs cannot be translated di- 
rectly to the clinical situation. Liver patients undergoing 
transplantation usually already have severe hemostatic 
disorders before the operation, which has an important in- 
fluence on the tendency for intraopertive bleeding [24]. 
Still, this study provided information on the hemostatic 
changes that occur intraoperatively and that are directly 
related to the transplantation procedure itself. 
A lower blood loss was found in the animals that under- 
went APLT than in those that underwent OLT. This is in 
accordance with our experience in clinical APLT [31], and 
can, at least partly, be explained by the difference in surgi- 
cal trauma, but this may very well be amplified by dif- 
ferences in the degree of intraoperative hemostatic dete- 
rioration. When comparing the hemostatic profile of the 
two groups, differences were not found in the blood 
coagulation system, but rather in the fibrinolytic system. 
In fact, the only minor changes in the routine clotting 
times, found in the OLT group, were comparable to the 
APLT group, without the anhepatic phase. This demon- 
strated that the changes are related to the surgical proce- 
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Fig.3. Postoperative course offibrinogen. AT-111, a2-AP andplatelet 
cowr in animals that underwent liver transplantation. 0 OLT 
(group A): APLT(group B)  (median values).A 2 h after surgery. 
P < 0.05, *' P c 0.01. comparison between group A and B 
dures in general, and not specifically due to the anhepatic 
phase in OLT. 
The only coagulation parameter that showed serious 
alteration was fibrinogen. A decrease in fibrinogen levels 
and subsequent prolongation of k value, representing clot 
formation rate, and a decrease in the MA value on TEG 
recordings, representing clot stiffness, were found in both 
OLT and APLT. Although the intraoperative decrease in 
fibrinogen levels was apparently more severe in OLT, this 
difference was not statistically significant. However, an 
ongoing postoperative decrease in fibrinogen levels after 
OLT did result in significantly lower levels compared with 
the APLTgroup 3 h after the operation. Several investiga- 
tors have described a reduction of fibrinogen levels in ex- 
perimental and clinical OLT [lo, 12,13,16,18,21]. Mech- 
anisms of consumption, DIC trapping in the graft, 
fibrinogenolysis and the effect of hemodilution have been 
suggested to explain this phenomenon [12,16,24]. We did 
not find convincing evidence for DIC and/or hemodilu- 
tion. AT-111 levels never reached extremely low values 
and no serious changes in any of the clotting times or he- 
matocrit were observed. The decrease in fibrinogen levels 
was most probably caused by a local Consumption around 
the surgical wounds. 
We also found signs of hyperfibrinolysis, as charac- 
terized by a shortened ECLTand decrease in plasminogen 
and a2-AP levels after graft recirculation in both groups. 
However, fibrinolytic activity was more severe and lasted 
longer in animals that underwent OLT. After recirculation 
of auxiliary grafts, the ECLT showed a fast normalization, 
and ECLT was normalized in this group at the time of 
completion of the hepatic artery anastomosis. Many in- 
vestigators have stressed the role of hyperfibrinolysis in 
the origin of bleeding complications in OLT. Recent 
studies in clinical OLT suggested that increased fibrino- 
lytic activity is predominantly of primary origin [12,16] 
and may result from a combination of reduced hepatic 
clearance and an increased release of tissue-type plasmi- 
nogen activator [6,25]. The lack of an anhepatic phase 
and the remnant clearing function of the host liver might 
explain why we observed less severe fibrinolytic activa- 
tion in APLT. In agreement with this, we recently demon- 
strated, in a clinical study, that signs of hyperfibrinolysis 
are only found in a minority of patients undergoing APLT 
[23]. Although the clinical relevance of hyperfibrinolysis 
in liver transplantation is still under discussion, this may 
be an important point of difference between OLT and 
APLT, and it may contribute to less frequent bleeding 
complications in APLT. 
Another difference between OLT and APLT, found in 
this study, was an earlier restoration of some hemostasis 
parameters after the operation. Levels of fibrinogen, a2- 
AP and AT-I11 were significantly higher in the APLT 
group on the first postoperative day. At first sight, this dif- 
ference can be explained well by the reduced functional 
capacity of the orthotopically transplanted liver, and the 
possibility cannot be excluded that this effect is predomi- 
nantly due to synthesis by the host liver in APLT. How- 
ever, clinical observations in cirrhotic patients with severe 
preoperative coagulation defects who underwent APLT 
showed a similar fast restoration of a2-AP and AT-111 le- 
vels [23,31]. Postoperatively, we observed a further de- 
crease in platelet count in both groups. This is in agree- 
ment with clinical findings [21], but the mechanisms 
underlying this drop in platelet count are still not clear and 
will be the subject of further research. 
The thrombocytosis observed in both groups after the 
first week can be ascribed to a reactively increased throm- 
bopoiesis. Rebound thrombocytosis occurs because of a 
lag in the feedback mechanism associated with the pla- 
teletlmegakaryocyte control mechanism [33]. In cirrhotic 
patients undergoing liver transplantation, a moderate to 
severe thrombocytopenia, due to splenomegaly, is usually 
present preoperatively. This may explain why such a 
thrombocytosis is less striking after successful clinical 
liver transplantations. 
In conclusion, in comparing OLT and APLT in a con- 
trolled study, we observed a halving of intraopertive blood 
loss in animals that underwent APLT. No differences in 
the investigated coagulation parameters were found be- 
tween the two groups. Although an increase in fibrinolytic 
activity was found during both types of liver transplanta- 
tion, signs of hyperfibrinolysis were present during a 
longer period after graft recirculation in OLT. Postopera- 
tively, an earlier normalization of disturbed hemostatic 
parameters was seen after APLT. It can be concluded that 
the anhepatic phase and reduced functional capacity of 
the donor liver during the early postreperfusion period 
play an important role in the hemostatic deterioration in 
OLT. Further clinical experience has to be awaited to 
determine the specific indications and advantages of 
APLT, compared to OLT. 
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